Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cancer therapy with vaccination using HLA-A02 restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study patients with unresectable colorectal cancer

ABSTRACT: Interventions: Vaccination Primary outcome(s): Safety Study Design: Single arm Non-randomized

DISEASE(S): Unresectable Colorectal Cancer

PROVIDER: 2616207 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Cancer therapy with vaccination using HLA-A24-restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study in patients with unresectable colorectal cancer

Project description:Interventions: Vaccination Primary outcome(s): Safety Study Design: Single arm Non-randomized

| 2616208 | ecrin-mdr-crc

Cancer therapy with vaccination using HLA-A24-restricted peptide from TOMM34:a phase I study in patients with unresectable colorectal cancer

Project description:Interventions: vaccination Primary outcome(s): Safety Study Design: Single arm Non-randomized

| 2616285 | ecrin-mdr-crc

Cancer therapy with vaccination using HLA-A24-restricted peptide from RNF43:a phase I study in patients with unresectable colorectal cancer

Project description:Interventions: vaccination Primary outcome(s): safety Study Design: Single arm Non-randomized

| 2616206 | ecrin-mdr-crc

Cancer therapy with vaccination using HLA-A02-restricted peptide from RNF43: a phase I study in patients with unresectable colorectal cancer

Project description:Interventions: Vaccination using epitope peptide from RNF43 Primary outcome(s): safety Study Design: Single arm Non-randomized

| 2616205 | ecrin-mdr-crc